Discover 1 curated intelligence briefings related to this specific topic.
The emergence of high-accuracy blood biomarkers like p-tau217 is shifting dementia diagnosis from a reactive event to a proactive surveillance model, creating a 20-year window of anticipation that challenges global healthcare infrastructures and the definition of patienthood.
